http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 13 Jun 2025 16:25:10 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html <p>23andMe Holding Co. (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement with TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and led by 23andMe Co-Founder and former CEO Anne Wojcicki, for the sale of substantially all of the Company’s assets, including the Personal Genome Service (PGS) and Research Services business lines and the Lemonaid Health business, for a purchase price of $305 million.</p><p>The agreement with TTAM is the result of a final round of bidding that occurred earlier today between TTAM and Regeneron Pharmaceuticals, Inc. http://www.streetinsider.com/Corporate+News/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html Fri, 13 Jun 2025 16:25:10 -0400 ME MEHCQ REGN http://www.streetinsider.com/Corporate+News/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html <p>23andMe Holding Co. (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement with TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and led by 23andMe Co-Founder and former CEO Anne Wojcicki, for the sale of substantially all of the Company’s assets, including the Personal Genome Service (PGS) and Research Services business lines and the Lemonaid Health business, for a purchase price of $305 million.</p><p>The agreement with TTAM is the result of a final round of bidding that occurred earlier today between TTAM and Regeneron Pharmaceuticals, Inc. http://www.streetinsider.com/Corporate+News/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html Fri, 13 Jun 2025 16:25:10 -0400 ME MEHCQ REGN http://www.streetinsider.com/Corporate+News/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html <p>23andMe Holding Co. (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement with TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and led by 23andMe Co-Founder and former CEO Anne Wojcicki, for the sale of substantially all of the Company’s assets, including the Personal Genome Service (PGS) and Research Services business lines and the Lemonaid Health business, for a purchase price of $305 million.</p><p>The agreement with TTAM is the result of a final round of bidding that occurred earlier today between TTAM and Regeneron Pharmaceuticals, Inc. http://www.streetinsider.com/Corporate+News/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html Fri, 13 Jun 2025 16:25:10 -0400 ME MEHCQ REGN http://www.streetinsider.com/Mergers+and+Acquisitions/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html <p>23andMe Holding Co. (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement with TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and led by 23andMe Co-Founder and former CEO Anne Wojcicki, for the sale of substantially all of the Company’s assets, including the Personal Genome Service (PGS) and Research Services business lines and the Lemonaid Health business, for a purchase price of $305 million.</p><p>The agreement with TTAM is the result of a final round of bidding that occurred earlier today between TTAM and Regeneron Pharmaceuticals, Inc. http://www.streetinsider.com/Mergers+and+Acquisitions/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html Fri, 13 Jun 2025 16:25:10 -0400 ME MEHCQ REGN http://www.streetinsider.com/Mergers+and+Acquisitions/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html <p>23andMe Holding Co. (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement with TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and led by 23andMe Co-Founder and former CEO Anne Wojcicki, for the sale of substantially all of the Company’s assets, including the Personal Genome Service (PGS) and Research Services business lines and the Lemonaid Health business, for a purchase price of $305 million.</p><p>The agreement with TTAM is the result of a final round of bidding that occurred earlier today between TTAM and Regeneron Pharmaceuticals, Inc. http://www.streetinsider.com/Mergers+and+Acquisitions/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html Fri, 13 Jun 2025 16:25:10 -0400 ME MEHCQ REGN http://www.streetinsider.com/Mergers+and+Acquisitions/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html <p>23andMe Holding Co. (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement with TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and led by 23andMe Co-Founder and former CEO Anne Wojcicki, for the sale of substantially all of the Company’s assets, including the Personal Genome Service (PGS) and Research Services business lines and the Lemonaid Health business, for a purchase price of $305 million.</p><p>The agreement with TTAM is the result of a final round of bidding that occurred earlier today between TTAM and Regeneron Pharmaceuticals, Inc. http://www.streetinsider.com/Mergers+and+Acquisitions/23andMe+%28MEHCQ%29+Reaches+Agreement+for+Sale+of+Business+to+TTAM+Research+Institute/24936226.html Fri, 13 Jun 2025 16:25:10 -0400 ME MEHCQ REGN http://www.streetinsider.com/Rumors/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html <p>Regeneron (NASDAQ: REGN): 23andMe Auction Process Was Recently Reopened and is "Fairly Complicated" - Goldman Sachs Conference</p><p> </p> http://www.streetinsider.com/Rumors/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html Mon, 09 Jun 2025 11:09:42 -0400 ME MEHCQ REGN http://www.streetinsider.com/Rumors/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html <p>Regeneron (NASDAQ: REGN): 23andMe Auction Process Was Recently Reopened and is "Fairly Complicated" - Goldman Sachs Conference</p><p> </p> http://www.streetinsider.com/Rumors/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html Mon, 09 Jun 2025 11:09:42 -0400 ME MEHCQ REGN http://www.streetinsider.com/Rumors/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html <p>Regeneron (NASDAQ: REGN): 23andMe Auction Process Was Recently Reopened and is "Fairly Complicated" - Goldman Sachs Conference</p><p> </p> http://www.streetinsider.com/Rumors/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html Mon, 09 Jun 2025 11:09:42 -0400 ME MEHCQ REGN http://www.streetinsider.com/Trader+Talk/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html <p>Regeneron (NASDAQ: REGN): 23andMe Auction Process Was Recently Reopened and is "Fairly Complicated" - Goldman Sachs Conference</p><p> </p> http://www.streetinsider.com/Trader+Talk/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html Mon, 09 Jun 2025 11:09:42 -0400 ME MEHCQ REGN http://www.streetinsider.com/Trader+Talk/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html <p>Regeneron (NASDAQ: REGN): 23andMe Auction Process Was Recently Reopened and is "Fairly Complicated" - Goldman Sachs Conference</p><p> </p> http://www.streetinsider.com/Trader+Talk/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html Mon, 09 Jun 2025 11:09:42 -0400 ME MEHCQ REGN http://www.streetinsider.com/Trader+Talk/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html <p>Regeneron (NASDAQ: REGN): 23andMe Auction Process Was Recently Reopened and is "Fairly Complicated" - Goldman Sachs Conference</p><p> </p> http://www.streetinsider.com/Trader+Talk/Regeneron+%28REGN%29+Executive%3A+23andMe+Auction+Process+Was+Recently+Reopened+and+is+%22Fairly+Complicated%22+-+Goldman+Sachs+Conference/24913317.html Mon, 09 Jun 2025 11:09:42 -0400 ME MEHCQ REGN http://www.streetinsider.com/Reuters/US+House+committee+seeks+testimony+from+23andMe+co-founder+after+bankruptcy/24638892.html <p>(Reuters) - A U.S. House committee on Tuesday asked 23andMe's co-founder to testify next month as it launched an investigation into the risk of genetic data being transferred to potential buyers amid the DNA testing company's bankruptcy.</p> <p>James Comer, a Republican from Kentucky and the chairman of the House Committee on Oversight and Government Reform, sent a letter to 23andMe's Anne Wojcicki, seeking her testimony on May 6 as http://www.streetinsider.com/Reuters/US+House+committee+seeks+testimony+from+23andMe+co-founder+after+bankruptcy/24638892.html Tue, 15 Apr 2025 07:07:11 -0400 ME http://www.streetinsider.com/General+News/US+House+committee+seeks+testimony+from+23andMe+co-founder+after+bankruptcy/24638892.html <p>(Reuters) - A U.S. House committee on Tuesday asked 23andMe's co-founder to testify next month as it launched an investigation into the risk of genetic data being transferred to potential buyers amid the DNA testing company's bankruptcy.</p> <p>James Comer, a Republican from Kentucky and the chairman of the House Committee on Oversight and Government Reform, sent a letter to 23andMe's Anne Wojcicki, seeking her testimony on May 6 as http://www.streetinsider.com/General+News/US+House+committee+seeks+testimony+from+23andMe+co-founder+after+bankruptcy/24638892.html Tue, 15 Apr 2025 07:07:11 -0400 ME http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24585208.html si-local-file:///var/storage/secattach/20250401/24585208.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24585208.html Tue, 01 Apr 2025 20:42:00 -0400 ME O.50740961 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24585208.html si-local-file:///var/storage/secattach/20250401/24585208.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24585208.html Tue, 01 Apr 2025 20:42:00 -0400 ME O.50740961 http://www.streetinsider.com/Reuters/FTC+concerned+about+privacy+protections+in+23andMe+bankruptcy/24572877.html <p>By Jody Godoy</p> <p>(Reuters) -The U.S. Federal Trade Commission is concerned about the potential sale or transfer of Americans' personal information by 23andMe ancestry testing company which recently filed for bankruptcy, the agency's chairman said on Monday.</p> <p>Any purchaser of 23andMe assets should agree to be bound by the company's existing privacy policy, FTC Chairman Andrew Ferguson said in a http://www.streetinsider.com/Reuters/FTC+concerned+about+privacy+protections+in+23andMe+bankruptcy/24572877.html Mon, 31 Mar 2025 12:28:54 -0400 ME http://www.streetinsider.com/General+News/FTC+concerned+about+privacy+protections+in+23andMe+bankruptcy/24572877.html <p>By Jody Godoy</p> <p>(Reuters) -The U.S. Federal Trade Commission is concerned about the potential sale or transfer of Americans' personal information by 23andMe ancestry testing company which recently filed for bankruptcy, the agency's chairman said on Monday.</p> <p>Any purchaser of 23andMe assets should agree to be bound by the company's existing privacy policy, FTC Chairman Andrew Ferguson said in a http://www.streetinsider.com/General+News/FTC+concerned+about+privacy+protections+in+23andMe+bankruptcy/24572877.html Mon, 31 Mar 2025 12:28:54 -0400 ME http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++23andMe+Holding+Co.+++++++For%3A+Mar+24/24566445.html si-local-file:///var/storage/secattach/20250328/24566445.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++23andMe+Holding+Co.+++++++For%3A+Mar+24/24566445.html Fri, 28 Mar 2025 16:09:00 -0400 ME O.50740961 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++23andMe+Holding+Co.+++++++For%3A+Mar+24/24566445.html si-local-file:///var/storage/secattach/20250328/24566445.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++23andMe+Holding+Co.+++++++For%3A+Mar+24/24566445.html Fri, 28 Mar 2025 16:09:00 -0400 ME O.50740961 http://www.streetinsider.com/Options/Increasing+unusual+option+volume%3A+ME+AMKR+HES+PACS+SLNO+BRZE+WOOF+CAR+MIST+YY+SAND+FE+/24562310.html <p>Increasing unusual option volume: ME AMKR HES PACS SLNO BRZE WOOF CAR MIST YY SAND FE</p> http://www.streetinsider.com/Options/Increasing+unusual+option+volume%3A+ME+AMKR+HES+PACS+SLNO+BRZE+WOOF+CAR+MIST+YY+SAND+FE+/24562310.html Fri, 28 Mar 2025 06:33:14 -0400 ME http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24561356.html si-local-file:///var/storage/secattach/20250327/24561356.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24561356.html Thu, 27 Mar 2025 20:41:00 -0400 ME O.50740961 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24561356.html si-local-file:///var/storage/secattach/20250327/24561356.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++23andMe+Holding+Co.++++++++++++++++++++Filed+by%3A+Zentree+Investments+Ltd/24561356.html Thu, 27 Mar 2025 20:41:00 -0400 ME O.50740961 http://www.streetinsider.com/Trading+Halts/23andMe+Holding+Co.+%28ME%29+Halted+on+Volatility%2C+Up+117%25/24556716.html <p>23andMe Holding Co. (NASDAQ: ME) Halted on Volatility, Up 117%</p><p> </p><p>Yesterday:</p><p> </p><p>23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has received approvals from the U.S. Bankruptcy Court for the Eastern District of Missouri (the “Court”) for its “first day” motions related to 23andMe’s voluntary Chapter 11 petitions filed March 23, 2025, including authorization to pay employee wages and benefits and compensate certain vendors and suppliers in the ordinary course for goods and services provided and to enter into the binding term sheet for a $35 million debtor-in-possession financing http://www.streetinsider.com/Trading+Halts/23andMe+Holding+Co.+%28ME%29+Halted+on+Volatility%2C+Up+117%25/24556716.html Thu, 27 Mar 2025 10:00:10 -0400 ME http://www.streetinsider.com/Corporate+News/23andMe+Holding+Co.+%28ME%29+Halted+on+Volatility%2C+Up+117%25/24556716.html <p>23andMe Holding Co. (NASDAQ: ME) Halted on Volatility, Up 117%</p><p> </p><p>Yesterday:</p><p> </p><p>23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has received approvals from the U.S. Bankruptcy Court for the Eastern District of Missouri (the “Court”) for its “first day” motions related to 23andMe’s voluntary Chapter 11 petitions filed March 23, 2025, including authorization to pay employee wages and benefits and compensate certain vendors and suppliers in the ordinary course for goods and services provided and to enter into the binding term sheet for a $35 million debtor-in-possession financing http://www.streetinsider.com/Corporate+News/23andMe+Holding+Co.+%28ME%29+Halted+on+Volatility%2C+Up+117%25/24556716.html Thu, 27 Mar 2025 10:00:10 -0400 ME